Organogenesis Holdings Inc (ORGO): Next-Year EPS Estimate 66.67%
As of 2026-06-11, Organogenesis Holdings Inc (ORGO) has a next-year EPS growth estimate of 66.67%.
On 2026-06-10, analyst consensus for ORGO's next-year EPS growth shifted from 66.46% to 66.67% — a positive change of 0.21 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -383.78%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 66.67%
- EPS growth this year
- -383.78%
- EPS next quarter (est)
- -$0.35
- Last price
- $2.38
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 66.67% | -383.78% | -$0.35 | $2.38 |
| 2026-06-10 | 66.67% | -383.78% | -$0.35 | $2.47 |
| 2026-06-09 | 66.46% | -383.32% | -$0.35 | $2.48 |
| 2026-06-08 | 66.46% | -383.32% | -$0.35 | $2.38 |
| 2026-06-07 | 66.46% | -383.32% | -$0.35 | $2.42 |
| 2026-06-04 | 66.46% | -383.32% | -$0.35 | $2.48 |
| 2026-06-03 | 66.46% | -383.32% | -$0.35 | $2.33 |
| 2026-06-02 | 66.46% | -383.32% | -$0.35 | $2.24 |
| 2026-06-01 | 66.46% | -383.32% | -$0.35 | $2.36 |
| 2026-05-31 | 66.46% | -383.32% | -$0.35 | $2.57 |
| 2026-05-28 | 66.46% | -383.32% | -$0.35 | $2.62 |
| 2026-05-27 | 68.92% | -355.68% | -$0.30 | $2.66 |
| 2026-05-26 | 68.92% | -355.68% | -$0.30 | $2.66 |
| 2026-05-25 | 68.92% | -355.68% | -$0.30 | $2.66 |
| 2026-05-24 | 68.92% | -355.68% | -$0.30 | $2.66 |
| 2026-05-21 | 68.92% | -355.68% | -$0.30 | $2.66 |
| 2026-05-20 | 68.92% | -355.68% | -$0.30 | $2.55 |
| 2026-05-19 | 68.92% | -355.68% | -$0.30 | $2.43 |
| 2026-05-18 | 68.92% | -355.68% | -$0.30 | $2.48 |
| 2026-05-17 | 68.92% | -355.68% | -$0.30 | $2.41 |
| 2026-05-14 | 68.92% | -355.68% | -$0.30 | $2.59 |
| 2026-05-13 | 68.92% | -355.68% | -$0.30 | $2.61 |
| 2026-05-12 | 68.92% | -355.68% | -$0.30 | $2.41 |
| 2026-05-11 | 68.92% | -355.68% | -$0.30 | $2.33 |
| 2026-05-10 | 68.92% | -355.68% | -$0.30 | $2.37 |
| 2026-05-07 | 270.59% | -158.74% | -$0.29 | $2.53 |
| 2026-05-06 | 270.59% | -158.74% | -$0.29 | $2.56 |
| 2026-05-05 | 270.59% | -158.74% | -$0.29 | $2.59 |
| 2026-05-04 | 270.59% | -158.74% | -$0.29 | $2.56 |
| 2026-05-03 | 270.59% | -158.74% | -$0.29 | $2.57 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Organogenesis Holdings Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Organogenesis Holdings Inc (ORGO) has a next-year EPS growth estimate of 66.67%, based on analyst consensus.
When was the latest EPS estimate revision for ORGO?▾
The most recent revision occurred on 2026-06-10, when analysts adjusted the next-year EPS growth estimate from 66.46% to 66.67%.
What sector and industry does Organogenesis Holdings Inc belong to?▾
Organogenesis Holdings Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ORGO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Organogenesis Holdings Inc (ORGO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports